Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.50 |
| ▸ | HTR1B | P28222 | 4/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.43 |
| ▸ | EPM2A | O95278 | 1/20 | 0.39 |
| ▸ | PTPRC | P08575 | 1/20 | 0.39 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.39 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.39 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.38 |
| ▸ | WNT3A | P56704 | 3/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.37 |
| ▸ | CDK9 | P50750 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11980461 | 0.87 | CHRM2 (0.51) | CYP2A6HTR1BSLC6A4MRGPRX4CHRM2 | |
| SCHEMBL28259822 | 0.84 | CYP2A6 (0.47) | CYP2A6HTR1BMRGPRX4EPM2APTPRC | |
| SCHEMBL6186816 | 0.79 | CYP2A6 (0.56) | CYP2A6HTR1BMRGPRX4EPM2APTPRC | |
| SCHEMBL29952165 | 0.79 | CYP2A6 (0.56) | CYP2A6HTR1BMRGPRX4EPM2APTPRC | |
| SCHEMBL10509017 | 0.77 | HTR1B (0.53) | CYP2A6HTR1BSLC6A4MRGPRX4CA2 | |
| Ethoxycarbonyl Group SCHEMBL27648948 | 0.75 | CYP2A6 (0.45) | CYP2A6HTR1BMRGPRX4CA2CTNNB1 | |
| SCHEMBL29956802 | 0.75 | CYP2A6 (0.51) | CYP2A6HTR1BMRGPRX4EPM2APTPRC | |
| SCHEMBL27689608 | 0.74 | HTR1B (0.53) | CYP2A6HTR1BMRGPRX4EPM2APTPRC | |
| SCHEMBL28014635 | 0.74 | LMNA (0.33) | — | |
| SCHEMBL4060791 | 0.74 | CA2 (0.51) | CYP2A6HTR1BSLC6A4MRGPRX4EPM2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106336416-A | Furan flavone derivative and preparation method thereof | 浙江大学 | 2017-01-18 | — | — | CN | claimed |
| CN-106478619-B | A kind of xanthine oxidase inhibitor and its application | 江苏新元素医药科技有限公司 | 2019-09-24 | — | — | CN | disclosed |
| CN-106749135-B | Substituted benzofuran formyl hydrazone analog derivative and preparation method thereof | 浙江大学 | 2019-07-19 | — | — | CN | disclosed |
| CN-109069514-A | Antimicrobial compound and application thereof | 结核病药物开发全球联盟公司 | 2018-12-21 | — | — | CN | disclosed |
| CN-106336416-A | Furan flavone derivative and preparation method thereof | 浙江大学 | 2017-01-18 | — | — | CN | disclosed |
| CN-1735441-A | Combination for treating attention deficit hyperactivity disorder | PHARMACIA & UPJOHN CO LLC (US) | 2006-02-15 | — | — | CN | disclosed |
| US-20050004126-A1 | Method of determining potential allosterically-binding matrix metalloproteinase inhibitors | ANDRIANJARA CHARLES (FR) | 2005-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050004126-A1 | Method of determining potential allosterically-binding matrix metalloproteinase inhibitors | MMP13, MMP12, MMP25 | CYP2A6 1243/4885HTR1B 957/4885SLC6A4 2654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.